{"id":"https://openalex.org/W7044054551","doi":null,"title":"Valoktokogeeniroksaparvoveekki (BMN 270) vaikean A-hemofilian hoidossa","display_name":"Valoktokogeeniroksaparvoveekki (BMN 270) vaikean A-hemofilian hoidossa","alternate_titles":[],"publication_year":2024,"publication_date":"2024-02-07","ids":{"openalex":"https://openalex.org/W7044054551"},"language":"fi","primary_location":{"id":"pmh:oai:www.julkari.fi:10024/148361","doi":null,"is_oa":true,"landing_page_url":"https://www.julkari.fi/handle/10024/148361","pdf_url":"https://www.julkari.fi/bitstreams/62a698cd-8172-4c0c-a700-914124f5f6b6/download","source":{"id":"https://openalex.org/S4306402058","display_name":"STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"D4"},"parent_works":[],"lineage":["https://openalex.org/W7044054551"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.julkari.fi/bitstreams/62a698cd-8172-4c0c-a700-914124f5f6b6/download","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Hyv\u00e4rinen, Antti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hyv\u00e4rinen, Antti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049520477","display_name":"Jarno Kotaj\u00e4rvi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kotaj\u00e4rvi, Jarno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044260788","display_name":"Janika E. N\u00e4ttinen","orcid":"https://orcid.org/0000-0002-7844-079X","observed_orcids":["https://orcid.org/0000-0002-7844-079X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"N\u00e4ttinen, Janika","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Ruotsalainen, Jani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ruotsalainen, Jani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recombinant-factor-viii","display_name":"recombinant factor VIII","score":0.6850000023841858},{"id":"https://openalex.org/keywords/aav5-vector","display_name":"AAV5 vector","score":0.6010000109672546},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.6510000228881836},{"id":"https://openalex.org/keywords/severe-hemophilia-a","display_name":"severe hemophilia A","score":0.7770000100135803},{"id":"https://openalex.org/keywords/hemophilia-a","display_name":"hemophilia A","score":0.5889999866485596},{"id":"https://openalex.org/keywords/f8-gene","display_name":"F8 gene","score":0.5590000152587891},{"id":"https://openalex.org/keywords/factor-viii-inhibitors","display_name":"factor VIII inhibitors","score":0.3610000014305115},{"id":"https://openalex.org/keywords/factor-viii-replacement-therapy","display_name":"factor VIII replacement therapy","score":0.4880000054836273},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.4300000071525574},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.5609999895095825},{"id":"https://openalex.org/keywords/adult-patients","display_name":"adult patients","score":0.4189999997615814},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.3869999945163727},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.4650000035762787}],"concepts":[{"id":"https://openalex.org/C144251240","wikidata":"https://www.wikidata.org/wiki/Q7068229","display_name":"Nucleofection","level":4,"score":0.31779998540878296},{"id":"https://openalex.org/C188198153","wikidata":"https://www.wikidata.org/wiki/Q1613840","display_name":"Limiting","level":2,"score":0.2615000009536743},{"id":"https://openalex.org/C18762648","wikidata":"https://www.wikidata.org/wiki/Q42213","display_name":"Work (physics)","level":2,"score":0.21719999611377716},{"id":"https://openalex.org/C99498987","wikidata":"https://www.wikidata.org/wiki/Q2210247","display_name":"Noise (video)","level":3,"score":0.19580000638961792},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.19580000638961792},{"id":"https://openalex.org/C61797465","wikidata":"https://www.wikidata.org/wiki/Q1188986","display_name":"Term (time)","level":2,"score":0.1875},{"id":"https://openalex.org/C126042441","wikidata":"https://www.wikidata.org/wiki/Q1324888","display_name":"Frame (networking)","level":2,"score":0.1777999997138977},{"id":"https://openalex.org/C106131492","wikidata":"https://www.wikidata.org/wiki/Q3072260","display_name":"Filter (signal processing)","level":2,"score":0.17520000040531158},{"id":"https://openalex.org/C2776356786","wikidata":"https://www.wikidata.org/wiki/Q1048573","display_name":"Tubulopathy","level":3,"score":0.1671999990940094},{"id":"https://openalex.org/C2778902089","wikidata":"https://www.wikidata.org/wiki/Q5608642","display_name":"Subpoena","level":2,"score":0.16660000383853912}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:www.julkari.fi:10024/148361","doi":null,"is_oa":true,"landing_page_url":"https://www.julkari.fi/handle/10024/148361","pdf_url":"https://www.julkari.fi/bitstreams/62a698cd-8172-4c0c-a700-914124f5f6b6/download","source":{"id":"https://openalex.org/S4306402058","display_name":"STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"D4"}],"best_oa_location":{"id":"pmh:oai:www.julkari.fi:10024/148361","doi":null,"is_oa":true,"landing_page_url":"https://www.julkari.fi/handle/10024/148361","pdf_url":"https://www.julkari.fi/bitstreams/62a698cd-8172-4c0c-a700-914124f5f6b6/download","source":{"id":"https://openalex.org/S4306402058","display_name":"STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"D4"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7044054551.pdf","grobid_xml":"https://content.openalex.org/works/W7044054551.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1925204833","https://openalex.org/W1993795505","https://openalex.org/W1996659702","https://openalex.org/W2008099224","https://openalex.org/W2020677481","https://openalex.org/W2095331703","https://openalex.org/W2266731009","https://openalex.org/W2602246456","https://openalex.org/W2888898681","https://openalex.org/W2972722566","https://openalex.org/W2998050720","https://openalex.org/W3003053451","https://openalex.org/W3047046471","https://openalex.org/W3157586694","https://openalex.org/W3189383694","https://openalex.org/W3208358152","https://openalex.org/W4200226516","https://openalex.org/W4210456579","https://openalex.org/W4212868305","https://openalex.org/W4221015126","https://openalex.org/W4321482598","https://openalex.org/W4327931973","https://openalex.org/W4381716341","https://openalex.org/W4386483398"],"related_works":["https://openalex.org/W2774984285","https://openalex.org/W3095941116","https://openalex.org/W4403554456","https://openalex.org/W4394797184","https://openalex.org/W3213346495","https://openalex.org/W2779486071","https://openalex.org/W4304014902","https://openalex.org/W4388598651","https://openalex.org/W4387045134","https://openalex.org/W7129231943"],"abstract_inverted_index":{"T\u00e4m\u00e4n":[0],"arvioinnin":[1],"tavoite":[2],"on":[3,21,26,50,68,90,107,187,566],"selvitt\u00e4\u00e4":[4],"kertahoitona":[5],"annosteltavan":[6],"geeniterapeuttisen":[7],"l\u00e4\u00e4kevalmisteen":[8],"valoktokogeeniroksaparvoveekin":[9],"(BMN":[10],"270)":[11],"hoidollisia":[12],"ja":[13,44,95,103,118,155,172,192,223,236,283,317,340,402,450,486,542,561,617],"taloudellisia":[14],"vaikutuksia":[15],"vaikean":[16,70],"A-hemofilian":[17,47,71],"hoidossa":[18],"aikuispotilailla.":[19],"A-hemofilia":[20],"verenvuotosairaus,":[22],"jonka":[23,216],"keskeinen":[24],"taudinaiheuttaja":[25],"h\u00e4iri\u00f6":[27],"F8-geenin":[28],"sekvenssiss\u00e4.":[29],"H\u00e4iri\u00f6st\u00e4":[30],"aiheutuu":[31],"riitt\u00e4m\u00e4t\u00f6n":[32],"tai":[33,60,80,408,525],"vajaatoiminen":[34],"hyytymistekij\u00e4":[35],"VIII":[36],"(FVIII)-tuotanto,":[37],"mik\u00e4":[38,99],"lopulta":[39],"johtaa":[40],"heikentyneeseen":[41],"veren":[42],"hyytymisprosessiin":[43],"verenvuotoherkkyyteen.":[45],"Nykyinen":[46],"hoidon":[48,170,631],"standardi":[49],"ollut":[51,78],"vaikeammissa":[52],"tautimuodoissa":[53],"suonensis\u00e4isesti":[54],"korvaushoitona":[55],"annettava":[56],"s\u00e4\u00e4nn\u00f6llinen":[57,528],"eksogeeninen":[58],"FVIII":[59],"emisitsumabi.":[61],"\\nValoktokogeeniroksaparvoveekki":[62],"eli":[63],"BMN":[64,115,143,201,228,249,265,297,334,349,356,382,397,419,464,478,498,515,534,543,556,596,598,626],"270":[65,557],"(myyntinimelt\u00e4":[66],"Roctavian)":[67],"tarkoitettu":[69],"hoitoon":[72],"potilaille,":[73],"joilla":[74],"ei":[75,391,558],"ole":[76],"aiemmin":[77],"FVIII-vasta-aineita":[79],"havaittavia":[81],"vasta-aineita":[82],"adenoassosioidun":[83],"viruksen":[84],"serotyypille":[85],"5":[86,425],"(AAV5).":[87],"Valmisteen":[88],"avulla":[89],"tarkoitus":[91],"saavuttaa":[92],"FVIII:n":[93],"pitk\u00e4kestoinen":[94],"kohonnut":[96],"tuotanto":[97],"maksasoluissa,":[98],"suojaa":[100],"potilasta":[101],"spontaaneilta":[102],"pitkittyneilt\u00e4":[104],"verenvuodoilta.":[105],"Valmiste":[106],"saanut":[108],"ehdollisen":[109],"myyntiluvan":[110,327,573],"Euroopassa":[111],"elokuussa":[112],"2022.":[113],"\\nN\u00e4ytt\u00f6":[114],"270:n":[116,383,398],"tehosta":[117,171],"turvallisuudesta":[119,173],"perustuu":[120,505],"p\u00e4\u00e4osin":[121],"faasin":[122],"III":[123],"avoimeen,":[124],"yksihaaraiseen":[125],"GENEr8-1-tutkimukseen,":[126],"johon":[127],"osallistui":[128],"134":[129],"vaikeasta":[130],"A-hemofiliasta":[131],"k\u00e4rsiv\u00e4\u00e4":[132],"aikuispotilasta.":[133],"Tutkimuksen":[134,146],"ensisijainen":[135],"lopputulosmuuttuja":[136],"oli":[137,233,241,247,358,476],"FVIII-aktiivisuustason":[138],"muutos":[139],"l\u00e4ht\u00f6tilanteesta":[140],"viikkoon":[141],"49\u201352":[142],"270-infuusion":[144],"j\u00e4lkeen.":[145,289],"toissijaisia":[147],"lopputulosmuuttujia":[148],"olivat":[149,351,423],"muutokset":[150],"FVIII-korvaushoidon":[151,291,301,339,344,407],"vuosittaisessa":[152],"k\u00e4yt\u00f6ss\u00e4":[153,302],"(IU/kg)":[154],"vuotuisten":[156],"FVIII-korvaushoitoa":[157],"vaativien":[158],"verenvuotojaksojen":[159],"(ABR,":[160],"annualized":[161],"bleeding":[162],"rate)":[163],"m\u00e4\u00e4r\u00e4ss\u00e4.":[164],"GENEr8-1-tutkimuksen":[165],"lis\u00e4ksi":[166],"pienempi":[167,248],"270-201-annoseskalaatiotutkimus":[168],"antaa":[169],"supportiivista":[174],"lis\u00e4n\u00e4ytt\u00f6\u00e4.":[175],"Arviointiraportissa":[176],"k\u00e4sitell\u00e4\u00e4n":[177],"p\u00e4\u00e4s\u00e4\u00e4nt\u00f6isesti":[178],"julkisista":[179],"l\u00e4hteist\u00e4":[180],"saatavilla":[181],"olevia":[182],"tuloksia,":[183],"jolloin":[184],"leikkauskohtana":[185],"GENEr8-1-tutkimukselle":[186],"15.11.2022":[188],"(kolmen":[189],"vuoden":[190,196,214,315,322,413,552,590],"seuranta)":[191],"270-201-tutkimukselle":[193],"29.3.2022":[194],"(kuuden":[195],"seuranta).":[197],"\\nGENEr8-1-tutkimuksen":[198],"tulosten":[199],"mukaan":[200],"270-hoidon":[202,250,465,479,499,535,544,599,627],"j\u00e4lkeen":[203,217,227,316,323,415],"FVIII-aktiivisuustasot":[204,422,434],"nousevat":[205],"yleens\u00e4":[206],"ensin":[207],"jyrk\u00e4sti":[208],"l\u00e4ht\u00f6tasosta":[209],"(\u22641":[210],"IU/dl)":[211],"noin":[212,417,576],"puolen":[213],"ajan,":[215],"ne":[218],"l\u00e4htev\u00e4t":[219],"laskuun":[220],"ennen":[221,296],"tasaantumista":[222],"hitaampaa":[224],"laskua.":[225],"Vuoden":[226],"270-annoksesta":[229],"hoitoaiepopulaation":[230],"FVIII-aktiivisuuden":[231],"mediaani":[232],"23,92":[234],"IU/dL":[235,426],"toisena":[237],"seurantavuotena":[238],"vastaava":[239],"arvo":[240],"11,65":[242],"IU/dL.":[243],"\\nVuosittaisten":[244],"verenvuotojen":[245,269,345,370,443],"m\u00e4\u00e4r\u00e4":[246,364],"j\u00e4lkeen,":[251],"tasaisesti":[252],"koholla":[253],"olevien":[254],"FVIII-aktiivisuustasojen":[255],"ansiosta.":[256],"GENEr8-1-tutkimuksessa":[257,299],"aiemmasta":[258,304],"tutkimuksesta":[259,305],"jatkavilla":[260,306],"potilailla":[261,307],"(n":[262,308],"=":[263,309],"112)":[264,310],"270-hoito":[266],"laski":[267],"hoidettujen":[268,367],"vuosittaista":[270],"m\u00e4\u00e4r\u00e4\u00e4":[271],"l\u00e4ht\u00f6tilanteen":[272],"keskim\u00e4\u00e4r\u00e4isest\u00e4":[273],"(SD)":[274],"4,83":[275],"(6,47)":[276],"vuotojaksosta":[277],"0,78":[278],"(2,99)":[279],"vuotojaksoon":[280,286],"ensimm\u00e4isen":[281,314,457],"seurantavuoden":[282,288],"0,75":[284],"(2,44)":[285],"toisen":[287,321],"My\u00f6s":[290],"k\u00e4ytt\u00f6m\u00e4\u00e4r\u00e4t":[292],"laskivat":[293],"verrattuna":[294,361],"seuranta-aikaan":[295],"270-annostelua.":[298],"eksogeenisen":[300],"havaittiin":[303],"98,6":[311],"%:n":[312,319],"v\u00e4hennys":[313,320],"98,2":[318],"l\u00e4ht\u00f6tilanteeseen":[324],"verrattuna.":[325,492,570],"\\nLis\u00e4ksi":[326],"haltija":[328,585],"toimitti":[329],"arviointiin":[330],"ep\u00e4suoria":[331],"vertailuja,":[332],"joissa":[333],"270-annoksen":[335],"j\u00e4lkeisi\u00e4":[336],"verenvuotojaksoja":[337,365],"verrattiin":[338],"emisitsumabin":[341,409,618],"vastaaviin":[342],"tuloksiin.":[343,355],"vuosittaisten":[346],"m\u00e4\u00e4rien":[347],"erot":[348],"270-hoitoon":[350],"verrattavissa":[352],"GENEr8-1-tutkimuksesta":[353],"saatuihin":[354],"270-hoidolla":[357],"my\u00f6s":[359],"emisitsumabiin":[360,491],"keskim\u00e4\u00e4r\u00e4isesti":[362],"alhaisempi":[363],"niin":[366,439],"verenvuotojen,":[368],"kaikkien":[369],"kuin":[371],"nivelvuotojenkin":[372],"osalta.":[373],"\\nFVIII-tasojen":[374],"hidas":[375],"mutta":[376],"jatkuva":[377],"lasku":[378],"vuosien":[379,540],"kuluessa":[380],"aiheuttaa":[381],"kliinisen":[384],"tehon":[385],"osalta":[386,480],"isoimman":[387],"ep\u00e4varmuuden;":[388],"nykyisell\u00e4":[389],"tutkimustiedolla":[390],"voida":[392],"varmasti":[393],"sanoa,":[394],"kuinka":[395],"pian":[396],"vaikutus":[399],"keskim\u00e4\u00e4rin":[400],"lakkaa":[401],"potilas":[403],"joutuu":[404],"palaamaan":[405],"s\u00e4\u00e4nn\u00f6llisen":[406,638],"k\u00e4yt\u00f6n":[410],"pariin.":[411],"Kahden":[412],"seuranta-ajan":[414],"kuitenkin":[416,495],"nelj\u00e4sosalla":[418],"270-hoidetuista":[420],"potilaista":[421,593],"alittaneet":[424],"-raja-arvon,":[427],"joka":[428],"m\u00e4\u00e4ritt\u00e4\u00e4":[429],"keskivaikeaa":[430],"A-hemofiliaa.":[431],"Useiden":[432],"tutkimuspotilaiden":[433],"ovat":[435,605],"siis":[436,538],"jo":[437],"l\u00e4hestym\u00e4ss\u00e4":[438],"matalia":[440],"arvoja,":[441],"ett\u00e4":[442,490,514,587],"todenn\u00e4k\u00f6isyyden":[444],"voidaan":[445],"olettaa":[446],"kasvavan.":[447],"\\nKaikki":[448],"GENEr8-1-":[449],"270-201-tutkimusten":[451],"potilaat":[452],"kokivat":[453],"v\u00e4hint\u00e4\u00e4n":[454],"yhden":[455],"haittatapahtuman":[456],"tutkimusvuoden":[458],"aikana.":[459],"Merkitt\u00e4vimm\u00e4ksi":[460],"havaituksi":[461],"riskiksi":[462],"tunnistettiin":[463],"j\u00e4lkeiset":[466],"maksahaitat,":[467],"jotka":[468],"edellytt\u00e4v\u00e4t":[469],"kortikosteroidihoitoa.":[470],"\\nMyyntiluvan":[471],"haltijan":[472,574],"kustannusvaikuttavuusanalyysiss\u00e4":[473],"inkrementaalinen":[474],"kustannusvaikuttavuus":[475,546],"dominoiva":[477],"sek\u00e4":[481],"s\u00e4\u00e4nn\u00f6lliseen":[482],"FVIII-korvaushoitoon":[483],"standardilla":[484],"(SHLpro)":[485],"pidennetyll\u00e4":[487],"(EHLpro)":[488],"puoliintumisajalla":[489],"Tuloksiin":[493],"liittyy":[494,512],"ep\u00e4varmuutta":[496],"erityisesti":[497],"vasteen":[500,507],"keston":[501,508],"osalta,":[502],"sill\u00e4":[503],"kustannusvaikuttavuustulos":[504],"oleellisesti":[506],"ekstrapolointiin.":[509],"Merkitt\u00e4vin":[510],"olettamus":[511],"siihen,":[513],"270-hoitoannoksen":[516],"saatuaan":[517],"A-hemofiliapotilaat":[518],"eiv\u00e4t":[519],"tarvitse":[520],"useisiin":[521],"vuosiin":[522],"kalliita":[523],"FVIII-korvaushoitoja":[524],"emisitsumabia,":[526],"joiden":[527],"k\u00e4ytt\u00f6":[529],"kerrytt\u00e4\u00e4":[530],"nopeasti":[531],"suuria":[532],"l\u00e4\u00e4kekustannuksia.":[533],"s\u00e4\u00e4st\u00f6t":[536],"kertyv\u00e4t":[537,641],"useiden":[539],"aikana":[541,591],"mallinnettu":[545],"ilmenee":[547],"kokonaisuudessaan":[548],"vasta":[549],"yli":[550],"10":[551],"tarkastelujaksolla.":[553],"Myyntiluvanhaltijan":[554],"perusanalyysiss\u00e4":[555],"tuo":[559],"elinaikahy\u00f6ty\u00e4":[560],"laatupainotetuissa":[562],"lis\u00e4elinvuosissa":[563],"saavutettava":[564],"hy\u00f6ty":[565],"melko":[567],"pieni":[568],"vertailuhoitoon":[569],"\\nFimea":[571],"pit\u00e4\u00e4":[572],"arviota":[575],"46":[577],"soveltuvasta":[578],"potilaasta":[579],"oikeansuuntaisena":[580],"perustuen":[581],"Kelan":[582],"l\u00e4\u00e4kekorvausaineistoihin.":[583],"Myyntiluvan":[584],"arvioi,":[586],"ensimm\u00e4isten":[588],"viiden":[589],"n\u00e4ist\u00e4":[592],"25":[594],"hoidettaisiin":[595],"270:lla.":[597],"l\u00e4\u00e4kekustannukset":[600],"(noin":[601,608,613,619],"1,8":[602],"miljoonaa":[603],"euroa)":[604,616,622],"huomattavasti":[606],"SHLpro-FVIII-korvaushoidon":[607],"190":[609],"000":[610,615,621],"euroa),":[611],"EHLpro-FVIII-korvaushoidon":[612],"212":[614],"351":[620],"potilaskohtaista":[623],"vuositasoa":[624],"korkeammat.":[625],"kustannukset":[628,640],"aiheutuvatkin":[629],"v\u00e4litt\u00f6m\u00e4sti":[630],"alussa":[632],"kertaluonteisen":[633],"investoinnin":[634],"muodossa,":[635],"kun":[636],"taas":[637],"A-hemofiliahoitojen":[639],"ajan":[642],"kuluessa.":[643]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7044054551","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2025-10-10T00:00:00"}
